Cagrilintide/Semaglutide 2.4mg+ 2.4mg

Cagrilintide/Semaglutide, also know as CagriSema, is a combo of the two and is being tested as treatment for type 2 diabetes, obesity, and metabolic dysfunction-associated steatohepatitis. (MASH).